Maytansine-antibody conjugates and methods of using same
Номер патента: EP4313009A1
Опубликовано: 07-02-2024
Автор(ы): Edward H. HA, Leonard G. Presta, Manish HUDLIKAR, Paul A. JAMINET, Robert Lutz, Shou-Ching S. JAMINET
Принадлежит: Angiex Inc
Опубликовано: 07-02-2024
Автор(ы): Edward H. HA, Leonard G. Presta, Manish HUDLIKAR, Paul A. JAMINET, Robert Lutz, Shou-Ching S. JAMINET
Принадлежит: Angiex Inc
Реферат: Antibody-drug conjugates (ADCs) are described, comprising anti-TM4SF1 antibodies, antigenbinding fragments thereof, a linker and a drug. The drug is an inhibitor of tubulin polymerization. Methods of use of the ADCs are also described.
Maytansine-antibody conjugates and methods of using same
Номер патента: AU2022245388A1. Автор: Leonard G. Presta,Robert Lutz,Shou-Ching S. JAMINET,Paul A. JAMINET,Edward H. HA,Manish HUDLIKAR. Владелец: Angiex Inc. Дата публикации: 2023-10-05.